Skip to content
OpenCapital
Get started

vTv Therapeutics VTVT Q1 2026 earnings

Reported May 13, 2026 · Before market open

Revenue$36.8MBeat by $16.8MDiluted EPS$1.65Beat by $1.31
Revenue estimate$20.0M
EPS estimate$0.34

Next report

Aug 11, 2026 (In 4 weeks)
Revenue estimate$333.3K
EPS estimate-$0.97

Versus estimates

Revenue

Q1 2026$36.8MBeat by $16.8M
Q4 2024$17.0K

Diluted EPS

Q1 2026$1.65Beat by $1.31
Q4 2025-$0.58Beat by $0.40Q3 2025-$1.08Miss by $0.11Q2 2025-$0.92Miss by $0.07Q1 2025-$0.77Miss by $0.04Q4 2024-$0.55Beat by $0.32

Ask the moment vTv Therapeutics reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

When did vTv Therapeutics report Q1 2026 earnings?
vTv Therapeutics (VTVT) reported Q1 2026 earnings on May 13, 2026 before market open.
What were vTv Therapeutics's Q1 2026 revenue and EPS?
vTv Therapeutics reported revenue of $36.8M and diluted EPS of $1.65 for Q1 2026.
Did vTv Therapeutics beat estimates in Q1 2026?
Revenue beat the consensus estimate of $20.0M by $16.8M. EPS beat the consensus estimate of $0.34 by $1.31.
Where can I find vTv Therapeutics's Q1 2026 SEC filings?
You can read the 8-K earnings release (0001641489-26-000019) and the 10-Q periodic report (0001641489-26-000020) directly on SEC EDGAR. The filing index links above go to sec.gov.